| Identification | Back Directory | [Name]
FK-3311 | [CAS]
116686-15-8 | [Synonyms]
CS-1073
FK-3311
FK-3311; FK3311
COX-2 Inhibitor V
COX-2 Inhibitor V, FK3311
N-[4-Acetyl-2-(2,4-difluorophenoxy)phenyl]methanesulfonamide
Methanesulfonamide, N-[4-acetyl-2-(2,4-difluorophenoxy)phenyl]-
N-[4-Acetyl-2-(2,4-difluorophenoxy)phenyl]-methanesulfonamide FK3311 | [Molecular Formula]
C15H13F2NO4S | [MDL Number]
MFCD00876455 | [MOL File]
116686-15-8.mol | [Molecular Weight]
341.33 |
| Chemical Properties | Back Directory | [Boiling point ]
431.3±55.0 °C(Predicted) | [density ]
1.419±0.06 g/cm3(Predicted) | [storage temp. ]
Store at RT | [solubility ]
Soluble in DMSO | [form ]
White solid | [pka]
6.82±0.10(Predicted) | [color ]
Light yellow to yellow | [InChI]
1S/C15H13F2NO4S/c1-9(19)10-3-5-13(18-23(2,20)21)15(7-10)22-14-6-4-11(16)8-12(14)17/h3-8,18H,1-2H3 | [InChIKey]
DIIYLGZNZGPXRR-UHFFFAOYSA-N | [SMILES]
Fc1c(ccc(c1)F)Oc2c(ccc(c2)C(=O)C)N[S](=O)(=O)C |
| Hazard Information | Back Directory | [Uses]
COX-2 Inhibitor V, FK3311 is a selective Cox-2 inhibitor and NSAID. | [Biological Activity]
Cyclooxygenase-2 (COX-2) inhibitor. Inhibits zymosan-induced prostaglandin E 2 production by rat peritoneal neutrophils in vitro and adjuvant-induced arthritis in vivo . Anti-inflammatory. | [in vivo]
L-PVR, CO, PaO(2), and WDR were significantly better in the FK group than in the control group. Histological tissue edema was mild, and PMN infiltration was significantly reduced in the FK group compared to the control group. The serum TxB(2) levels were significantly lower in the FK group than in the control group, while 6-keto-PGF(1alpha) levels were not significantly reduced. Two-day survival rate was significantly better in the FK group than in the control group[2].
Survival rate was significantly better and serum GOT levels 30 min after reperfusion were significantly lower in the FK high-dose group compared to the other two groups. Four hours after reperfusion, GPT levels and liver tissue flow were significantly better in the FK high-dose group compared to the control. Both 30 min and 4 hr after reperfusion, serum TxB(2) levels were significantly lower in the FK high-dose group compared to the control[3].
| [IC 50]
COX-2 |
|
| Company Name: |
LETOPHARM LIMITED
|
| Telephone: |
+86-21-5821 5861 |
| Website: |
www.letopharm.com |
| Company Name: |
D&C Chemicals
|
| Telephone: |
+86-21-58447131 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList16963/0_EN.htm |
|